Biotechnology Companies By Beta
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Beta
| Beta | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | BRTX | BioRestorative Therapies | 0.07 | 6.25 | 0.44 | ||
| 2 | ERNA | Eterna Therapeutics | 0.06 | 11.16 | 0.61 | ||
| 3 | MDCX | Medicus Pharma Ltd | 0.08 | 8.62 | 0.67 | ||
| 4 | APVO | Aptevo Therapeutics | (0.17) | 5.15 | (0.87) | ||
| 5 | CELZ | Creative Medical Technology | 0.10 | 8.96 | 0.87 | ||
| 6 | CAPR | Capricor Therapeutics | 0.00 | 5.32 | (0.02) | ||
| 7 | BHVN | Biohaven Pharmaceutical Holding | (0.09) | 3.72 | (0.32) | ||
| 8 | OCGN | Ocugen Inc | (0.05) | 4.73 | (0.24) | ||
| 9 | XCUR | Exicure | 0.01 | 11.81 | 0.14 | ||
| 10 | CDIOW | Cardio Diagnostics Holdings | (0.02) | 16.80 | (0.33) | ||
| 11 | CDIO | Cardio Diagnostics Holdings | (0.12) | 8.66 | (1.01) | ||
| 12 | VANI | Vivani Medical | (0.06) | 1.83 | (0.12) | ||
| 13 | CRIS | Curis Inc | (0.03) | 6.20 | (0.17) | ||
| 14 | GLSI | Greenwich Lifesciences | (0.04) | 2.98 | (0.11) | ||
| 15 | CHHL | China Holdings | 0.00 | 0.00 | 0.00 | ||
| 16 | CLLS | Cellectis SA | (0.02) | 6.30 | (0.14) | ||
| 17 | ONCO | Onconetix | (0.09) | 11.58 | (1.03) | ||
| 18 | JANX | Janux Therapeutics | (0.24) | 4.08 | (0.98) | ||
| 19 | BTX | BlackRock Technology and | (0.39) | 1.88 | (0.73) | ||
| 20 | BIAFW | bioAffinity Technologies Warrant | 0.04 | 19.26 | 0.86 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time. In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.